Literature DB >> 28677845

Detection of peripheral embolic consolidations using contrast-enhanced ultrasonography in patients with no evidence of pulmonary embolism on computed tomography: A pilot study.

C Trenker1, J C Apitzsch2, S Pastor3, S Bartelt3, A Neesse4, C Goerg3.   

Abstract

AIM: To investigate the value of B-mode imaging and contrast-enhanced ultrasonography (CEUS) in patients with clinically suspected pulmonary embolism (PE) but no evidence of central PE on CT.
METHODS: Between May 2004 and February 2015, we included in this retrospective study 19 patients with a risk profile for PE according to their Wells' score, sonographic patterns of peripheral embolic consolidations (EC) on B-mode-imaging and CEUS (ie, missing or inhomogeneous enhancement of the pleural lesions), and exclusion of central PE by CT within 1 week of CEUS.
RESULTS: On B-mode imaging, 19 pleural defects presented as hypoechoic. The shape of EC was round in 2, wedge-shaped in 12, polygonal in 3, and presented as atelectasis in 2 cases. On CEUS, 5 of the defects demonstrated, at the arterial and parenchymal phase, a lack of enhancement, and 14 showed an inhomogeneous (mixed) enhancement with wedge-shaped peripheral areas of no contrast enhancement. A second radiologic evaluation of the CT scans revealed PE in two patients and lesions suspicious for malignancy in two other patients.
CONCLUSIONS: Despite the lack of definite confirmation of peripheral and central PE on CT, peripheral pleural consolidations with no or inhomogeneous enhancement on CEUS, in combination with the risk profile for a PE, are highly suggestive of EC. If there is still some doubt, histologic confirmation is important to confirm EC and exclude malignancy. Thus, CEUS may close a potential diagnostic gap of small peripheral PE on CT.
© 2017 Wiley Periodicals, Inc. J Clin Ultrasound 45:575-579, 2017. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  contrast-enhanced ultrasonography (CEUS); lung; no evidence in CT; pulmonary embolism

Mesh:

Substances:

Year:  2017        PMID: 28677845     DOI: 10.1002/jcu.22511

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  6 in total

1.  Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 patient.

Authors:  Alice Tee; Adrian Wong; Gibran Timothy Yusuf; Deepak Rao; Paul S Sidhu
Journal:  Intensive Care Med       Date:  2020-05-18       Impact factor: 17.440

Review 2.  [Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine and critical care (CEUS Acute) : Consensus statement of DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM and DEGUM].

Authors:  Guido Michels; Rudolf Horn; Andreas Helfen; Andreas Hagendorff; Christian Jung; Beatrice Hoffmann; Natalie Jaspers; Horst Kinkel; Clemens-Alexander Greim; Fabian Knebel; Johann Bauersachs; Hans-Jörg Busch; Daniel Kiefl; Alexander O Spiel; Gernot Marx; Christoph F Dietrich
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-02       Impact factor: 0.840

Review 3.  Lung aeration, ventilation, and perfusion imaging.

Authors:  Lorenzo Ball; Gaetano Scaramuzzo; Jacob Herrmann; Maurizio Cereda
Journal:  Curr Opin Crit Care       Date:  2022-06-01       Impact factor: 3.359

4.  Perfusion Patterns of Peripheral Pulmonary Lesions in COVID-19 Patients Using Contrast-Enhanced Ultrasound (CEUS): A Case Series.

Authors:  Ehsan Safai Zadeh; Björn Beutel; Christoph Frank Dietrich; Corinna Ulrike Keber; Katharina Paulina Huber; Christian Görg; Corinna Trenker
Journal:  J Ultrasound Med       Date:  2021-01-18       Impact factor: 2.754

5.  Contrast enhanced ultrasound (CEUS) to assess pleural pulmonal changes in severe COVID-19 infection: First results.

Authors:  E M Jung; C Stroszczynski; F Jung
Journal:  Clin Hemorheol Microcirc       Date:  2020       Impact factor: 2.375

6.  Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients.

Authors:  Viviane Zotzmann; Corinna N Lang; Tobias Wengenmayer; Xavier Bemtgen; Bonaventura Schmid; Katharina Mueller-Peltzer; Alexander Supady; Christoph Bode; Daniel Duerschmied; Dawid L Staudacher
Journal:  J Thromb Thrombolysis       Date:  2020-11-03       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.